ArticleDrugs - real world outcomes2025

Safety and Effectiveness of Brigatinib in Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Post-Marketing Surveillance Study.

Claudio Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.